BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3067412)

  • 1. [Renal effects of captopril in chronic heart failure].
    Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
    Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Captopril in the treatment of refractory cardiac insufficiency].
    Gorb IuG
    Ter Arkh; 1985; 57(12):63-7. PubMed ID: 3911466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J; Lalonde G; Bichet D; Rouleau JL
    Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Captopril in the treatment of arterial hypertension in chronic nephritis].
    Kutyrina IM; Rogov VA; Lifshits NL; Klepikov PV
    Ter Arkh; 1986; 58(8):92-6. PubMed ID: 3532416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of diltiazem hydrochloride upon sodium diuresis and renal function in chronic congestive heart failure.
    Kinoshita M; Kusukawa R; Shimono Y; Motomura M; Tomonaga G; Hoshino T
    Arzneimittelforschung; 1979; 29(4):676-81. PubMed ID: 582767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nifedipine on renal activity].
    Merzon AK; Donskova TV; Zolotov NA; Kolomiets VV; Merzon KA
    Ter Arkh; 1988; 60(6):74-9. PubMed ID: 3206377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Pedersen EB
    Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of captopril in the treatment of patients with severe forms of chronic heart failure].
    Irani RM
    Ter Arkh; 1986; 58(11):55-8. PubMed ID: 3547747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W; Halawa B
    Pol Merkur Lekarski; 1997 Sep; 3(15):105-8. PubMed ID: 9461703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.